Cats Could Be Unexpected Allies in the Fight Against Cancer

An international study has revealed that tumors in domestic cats share key genetic alterations with those found in humans, suggesting that felines could play a significant role in the effort to understand and treat breast cancer.

The research, published in the journal Science, indicates that genetic mutations driving cancer development in cats often coincide with those observed in humans. This discovery opens the door to exploring shared therapeutic pathways that could benefit both human patients and animals.

Study Methodology and Scope

The study was led by the Wellcome Trust Sanger Institute in collaboration with the University of Bern and the Ontario Veterinary College. Researchers analyzed the DNA of tumors from nearly 500 domestic cats across five different countries.

To identify parallels between species, the team studied approximately 1,000 genes associated with human cancer. These genes were examined across 13 different types of feline tumors and compared against healthy tissue samples.

The analysis concluded that many of the genetic changes responsible for causing cancer in cats are comparable to those found in both humans and dogs.

Key Genetic Findings in Mammary Carcinomas

The most significant parallels were identified in feline mammary carcinomas, which are described as a common and aggressive form of cancer in cats. Within these tumors, the researchers identified seven key driver genes that, when mutated, drive the development of the disease.

The most prevalent mutation occurred in the FBXW7 gene, which was altered in more than 50% of the feline tumors analyzed. In human patients, mutations in the FBXW7 gene are associated with a worse prognosis in breast cancer, indicating a direct biological parallel between the two species.

The second most common mutation was found in the PIK3CA gene, which appeared in 47% of the cat mammary tumors. This specific gene is also involved in human breast cancer and is currently the target of specialized therapies using PI3K inhibitors.

Implications for Cancer Treatment

Because the genetic mutations causing cancer are so similar in cats and humans, researchers suggest that felines may serve as a vital partner in the fight against cancer.

The identification of these shared genetic drivers allows scientists to better understand the mechanisms of breast cancer. It suggests that treatments developed for humans might be adapted for pets, and conversely, the study of feline tumors could provide insights that lead to improved treatments for human patients.

By analyzing these shared therapeutic pathways, medical and veterinary professionals may be able to develop more effective targeted therapies based on the specific genetic mutations driving the tumor growth in both species.